IVF Success Rates for Women Over 40
Few questions come up more often in a first consultation than this one: at my age, does IVF actually work? It's the right question to ask, and it deserves a straight answer rather than a single headline number. The honest version is more nuanced — and, in some ways, more hopeful — than the blunt statistics often suggest.
At Indiana Fertility Institute (IFI), our aim is to give every patient a realistic, individualized picture of what treatment can and can't do after 40, so decisions are grounded in evidence rather than optimism or fear. This blog walks through what the current national data shows, what's really driving the age-related decline, and the options that meaningfully change the odds.
A note on the numbers below: these are aggregate figures reported by the Society for Assisted Reproductive Technology (SART) across all U.S. member clinics for 2024. They describe national trends for educational purposes and are not specific to any single clinic. Individual prognosis depends on many personal factors and is best discussed with your physician.
What actually changes with age
The most important thing to understand is that age doesn't lower your chances everywhere at once. It concentrates the effect at one specific step: producing a chromosomally normal (euploid) embryo.
As we get older, a larger share of eggs — and therefore embryos — carry the wrong number of chromosomes. These embryos usually fail to implant, or result in early miscarriage. This is a biological feature of egg aging, and it's the single largest driver of the drop-off after 40. By around age 40, roughly one in three embryos that reach the blastocyst stage is chromosomally normal; by 43 and beyond, fewer than one in five.
Here's the part that surprises most patients: once a chromosomally normal embryo is available to transfer, the chance of a live birth from that transfer is broadly similar regardless of age. In the 2024 national SART data, live birth per single euploid embryo transfer was about 55% under age 35 and still roughly 50% for women over 42. A 2026 analysis reached the same conclusion — no meaningful difference in success per transfer across age groups when a euploid embryo was transferred.
So the age penalty is mostly upstream. It's not that transfers stop working after 40; it's that it becomes harder to get a normal embryo to transfer in the first place.
What the numbers look like
Reading the funnel from egg retrieval forward makes the pattern clear. In the 2024 national SART data for cycles using a patient's own eggs:
-
The average number of eggs retrieved per cycle falls with age — from about 18 under 35 to roughly 8 over 42.
-
The share of retrievals that produce no embryo suitable to transfer or freeze rises steadily: about 8% under 35, 25% at 41–42, and 38% over 42.
-
The average number of embryos available per retrieval drops from around 5–6 under 35 to about 1 over 42.
That same 2026 study captured the combined effect in a single figure: the probability of a successful pregnancy per egg retrieval fell from about 29% for women under 35 to about 5% for women over 40. The steep number people fear is real — but it lives at the whole-cycle level, driven by embryo attrition, not at the transfer itself.
One caveat worth naming: the encouraging "per euploid transfer" figures only count embryos that were biopsied and found suitable to transfer. They don't include cycles that produced no transferable embryo. Both facts are true at once, and both matter — which is exactly why a realistic conversation looks at the full path, not one number in isolation.
Options that change the math
Understanding where age exerts its effect points directly to what can help.
Preimplantation genetic testing for aneuploidy (PGT-A). PGT-A screens embryos for the right number of chromosomes before transfer. It doesn't create more normal embryos or reverse egg aging — but it can identify which embryos are worth transferring, which tends to reduce failed transfers and miscarriages and can shorten the path to a successful pregnancy. Its value is greatest for women who produce several embryos to screen.
Ovarian reserve testing and expectations. An AMH test helps predict how many eggs a stimulation cycle is likely to yield, which in turn shapes how many embryos — and how many normal embryos — you might expect. AMH is a guide to egg quantity, not egg quality; quality tracks with age. Reviewing your AMH alongside your age is one of the most useful early steps in setting realistic expectations, and it's part of a standard fertility evaluation.
Multiple cycles. Because so much of the challenge is producing a euploid embryo, more than one retrieval is sometimes what it takes to bank enough embryos to work with. Multi-cycle financial plans exist partly for this reason.
Donor eggs. This is the option that most dramatically changes the odds after 40, because it addresses the root cause directly. Since egg age — not the age of the person carrying the pregnancy — drives the euploid rate, using donor eggs resets that part of the equation. In the 2024 national SART data, live birth per transfer with donor eggs ran in the high 30s to mid 40s percent, largely independent of the recipient's age.
Choosing donor eggs is also a significant decision, emotionally and financially, and it isn't the right path for everyone. Many people need time to consider what a genetic connection means to them, to talk it through with a partner, and to understand the costs and financing involved. There's no correct timeline for that. What matters is having accurate information early, so the choice — in whichever direction — is made with clear eyes rather than under pressure.
Frequently asked questions
Is 40 too old to try IVF with my own eggs? Not automatically. Many women in their early 40s conceive with their own eggs, particularly when several embryos can be produced and screened. What changes is that the odds per cycle are lower and often more variable, so it's worth going in with a clear, individualized estimate rather than a general average.
Why do success rates drop so much after 40? Almost entirely because of embryo chromosomal normality. Older eggs are more likely to produce embryos with the wrong number of chromosomes, which usually don't implant or result in miscarriage. Once a chromosomally normal embryo is transferred, age has much less effect on the outcome.
Does PGT-A improve my chances after 40? PGT-A doesn't increase the number of normal embryos you have, but it can help identify them — which tends to reduce failed transfers and miscarriages. It's most useful when there are several embryos to screen. Whether it's right for you depends on your specific situation.
What does my AMH level tell me? AMH predicts how many eggs a cycle is likely to yield — a measure of quantity, not quality. It's a helpful planning tool, but it doesn't by itself predict whether an embryo will be chromosomally normal. Your physician will interpret your AMH in the context of your age and goals.
Should I consider donor eggs? For many women over 40, donor eggs offer substantially higher and more predictable success rates because they address egg age directly. It's also a major decision emotionally and financially, and entirely a personal one. It's worth understanding as an option early, even if you decide to pursue treatment with your own eggs first.
The bottom line
The statistics for IVF after 40 look daunting when compressed into one number, but they tell a more specific story once you look closer: the challenge is producing a chromosomally normal embryo, and once you have one, your age matters far less. That's why an honest, individualized assessment — your age, your ovarian reserve, and the full range of options including PGT-A and donor eggs — is worth so much more than any headline average.
If you'd like a realistic picture of your own chances, the best next step is a conversation. Request a consultation with our team, and we'll walk through the numbers that actually apply to you.